Summit Therapeutics Inc. Common Stock

SMMTNASDAQ • USD
10.63 USD
↘ 3.52 (24.86%)🟢PRE MARKET (AS OF 04:06 AM EST)
🟢Market: OPEN

Shares of Summit Therapeutics Inc. Common Stock (SMMT) are trading at $10.63. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, SMMT trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 13, 2026.

Open?$14.16
High?$14.16
Low?$9.54
Prev. Close?$14.15
Volume?119.8K
Avg. Volume?5.1M
VWAP?$10.39
Rel. Volume?0.02x
Bid / Ask
Bid?$13.50 × 100
Ask?$14.17 × 100
Spread?$0.67
Midpoint?$13.84
Valuation & Ratios
Market Cap?11.3B
Shares Out?799.8M
Float?138.5M
Float %?17.4%
P/E Ratio?N/A
P/B Ratio?20.04
EPS?-$1.04
Dividend?0.00%
Ex-Dividend?N/A
RelatedMRKLPA
News
Profile
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Employees
265
Market Cap
11.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-03-05
Address
601 BRICKELL KEY DRIVE
MIAMI, FL 33131
Phone: 305-203-2034
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?43.98Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?30.52%Squeeze Risk
Short Interest?42.3M
Days to Cover?9.4
Free Float138.5M
Avg Daily Volume4.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.99Strong
Quick Ratio?5.99Strong
Cash Ratio?1.37Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
50
S&P
7
20.04HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
-13.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
3
-147.5%WEAK▾
ROA?
Peers
50
S&P
3
-120.2%WEAK▾
Cash Flow & Enterprise
FCF?$-526881000
Enterprise Value?$11.2B
Fundamentals ratios updated end of day